Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
for Relapsed/Refractory KMT2A-r Acute Leukemia
11 locations incl. Los Angeles
Sponsor: PedAL BCU, LLC
Sex: All·Age: 0 - 21
Code: NCT06376162·Phase 1·Recruiting